Abstract:Gastric cancer's (GC) incidence shows large geographic differences worldwide with the lowest rates occurring in most Western industrialized countries including the United States and the United Kingdom; in contrast, relatively high rates of GC occur in Japan, Korea, China, and South America, particularly Chile. The Laurén classification system classifies GC under two major histopathological variants: 1) an intestinal type and 2) a diffuse type. The intestinal type is more common in the general population, more likely to be sporadic and related to environmental factors such as diet, particularly salted fish and meat as well as smoked foods, cigarette smoking, and alcohol use. It exhibits components of glandular, solid, or intestinal architecture, as well as tubular structures. On the other hand, the diffuse type is more likely to have a primary genetic etiology, a subset of which, known as hereditary diffuse gastric cancer (HDGC), is due to the E-cadherin (CDH1) germline mutation. The diffuse type pathology is characterized by poorly cohesive clusters of cells which infiltrate the gastric wall, leading to its widespread thickening and rigidity of the gastric wall, known as linitis plastica. Helicobacter pylori infection is associated with risk for both the intestinal and diffuse varieties of gastric cancer. Germline truncating mutations of the CDH1 gene, which codes for the E-cadherin protein, were initially identified in three Maori families from New Zealand that were predisposed to diffuse GC. Since then, similar mutations have been described in more than 40 additional HDGC families of diverse ethnic backgrounds. It is noteworthy that two-thirds of HDGC families reported to date have proved negative for the CDH1 germline mutation. A number of candidate genes have been identified through analysis of the molecular biology of E-cadherin. Patients with evidence of the CDH1 germline mutation in the context of a family history of HDGC must be considered as candidates for prophylactic gastrectomy, given the extreme difficulty in its early diagnosis and its exceedingly poor prognosis when there is regional or distant spread. Specifically, the E-cadherin cytoplasmic tail interacts with catenins, assembling the cell-adhesion complex involved with E-cadherin mediated cell:cell adhesion. Beta-catenin and gamma-catenin compete for the same binding site on the E-cadherin cytoplasmic tail, directly linking the adhesion complex to the cytoskeleton through alpha-catenin. Beta-catenin gene (CTNNB1) mutations have been described predominantly in intestinal-type gastric cancers and CTNNB1 gene amplification and overexpression have recently been described in a mixed-type gastric cancer. This paper reviews the genetics of both intestinal and diffuse types of gastric carcinoma, their differential diagnosis, molecular genetics, pathology, and, when known, their mode of genetic transmission within families.

The Germline Mutaion Pattern Of Cdh1 Gene In 12 Chinese Hereditary Diffuse Gastric Cancer Kindred.

Germline Mutational Analysis of CDH1 and Pathologic Features in Familial Cancer Syndrome with Diffuse Gastric Cancer/breast Cancer Proband in a Chinese Family.

Germline E-cadherin Gene Mutation Screening in Familial Gastric Cancer Kindreds

NovelCDH1germline Mutations Identified in Chinese Gastric Cancer Patients

[Associations of E-cadherin Gene (CDH1) and Hereditary Gastric Cancer in China].

The Study of Family Heredity of Gastric Cancer in China

Germline Mutations And Polymorphic Variants In Mmr, E-Cadherin And Myh Genes Associated With Familial Gastric Cancer In Jiangsu Of China

A Multi-Institutional Investigation Assessing Prevalence of Germline Genetic Alterations in Chinese Patients with Gastric Carcinoma.

A Multicenter Study Assessing the Prevalence of Germline Genetic Alterations in Chinese Gastric-Cancer Patients

Whole-Exome Sequencing Among Chinese Patients With Hereditary Diffuse Gastric Cancer

Germline promoter hypermethylation of tumor suppressor genes in gastric cancer

Clinical and genetic characteristics of Chinese hereditary nonpolyposis colorectal cancer families.

Germline mutations in hereditary diffuse gastric cancer

CDH1 mutational analysis and pathologic study of a Chinese familial cancer syndrome with diffuse type gastric cancer/breast cancer proband

Profiling of the genetic features of Chinese patients with gastric cancer with HRD germline mutations in a large-scale retrospective study

Mutational landscape of TP53 and CDH1 in gastric cancer

Pathogenic Germline Mutations in Chinese Patients with Gastric Cancer Identified by Next-Generation Sequencing

Clinical and genetic characterization of Chinese hereditary nonpolyposis colorectal cancer families

Gastric cancer: New genetic developments

Clinical Features and Hmsh2/hmlh1 Germline Mutation Screening of Chinese Hereditary Nonpolyposis Colorectal Cancer Patients

Progress in Diagnosis and Treatment of Hereditary Diffuse Gastric Cancer